Corporate Announcement
Security Code : 524404    Company : MARKSANS    
 
Marksans Pharma - Press ReleaseDownload PDF
  Exchange Disseminated Time     
Marksans Pharma Ltd has informed BSE regarding a Press Release dated July 21, 2009 titled "Marksans Pharma Limited announces USFDA approval of generic Ibuprofen Capsules (Liquid Filled), 200 mg for Advil Liqui - Gels 200 mg."

Press Release:

"Marksans Pharma Ltd hereby announces that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for generic Ibuprofen Capsules (Liquid Filled), 200 mg.

The generic version of Ibuprofen Capsules (Liquid Filled) 200 mg manufactured by Marksans Pharma Ltd is bioequivalent to a brand name drug product Advil Liqui - Gels 200 mg of Wyeth Consumer Healthcare (Advil Liqui - Gels is a registered trademark of Wyeth Consumer Healthcare) in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.

Marksans Pharma Ltd has commenced manufacturing of the same at its USFDA approved state-of-the-art solid oral dosage facility located at Goa, India."
 

Disclaimer

Back To Announcements